A hospital ward

Pfizer Tackles Antimicrobial Resistance

Modern medicine depends on antibiotics to help prevent and treat infections. Alarmingly, many are losing their effectiveness due to antimicrobial resistance (AMR).

If antibiotics become ineffective, common infections could result in hospitalization or death. Life-saving interventions and routine procedures would become more difficult or impossible.

AMR can affect anyone. It causes 700,000 deaths annually worldwide, a number projected to skyrocket to 10 million by 2050 without intervention.

Pfizer is proud to partner with the infectious disease community and play a leading role in the fight against AMR through:

  • Active stewardship
  • Innovative surveillance tools, like ATLAS (Antimicrobial Testing Leadership and Surveillance)
  • Global policy leadership
  • A diverse portfolio of anti-infective medicines and vaccines
  • Responsible manufacturing practices
Go back

Explore Our Innovation